logo

ASMB

Assembly Biosciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ASMB fundamentals

Assembly Biosciences (ASMB) released its earnings on Nov 10, 2025: revenue was 10.79M (YoY +57.62%), beat estimates; EPS was -0.72 (YoY +52.32%), missed estimates.
Revenue / YoY
10.79M
+57.62%
EPS / YoY
-0.72
+52.32%
Report date
Nov 10, 2025
EPS
Revenue

Revenue & Expenses

ASMB has released its 2025 Q3 earnings report, with revenue of 10.79M, reflecting a YoY change of 57.62%, and net profit of -9.20M, showing a YoY change of 4.34%. The Sankey diagram below clearly presents ASMB's revenue sources and cost distribution.

Key Indicators

Assembly Biosciences (ASMB) key financial stats and ratios, covering profitability, financial health, and leverage.
Assembly Biosciences (ASMB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Assembly Biosciences (ASMB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Assembly Biosciences (ASMB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Assembly Biosciences (ASMB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Assembly Biosciences (ASMB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield